Institutional members access full text with Ovid®

Share this article on:

Two Doses of Subcutaneous Ustekinumab Based on Body Weight Provide Similar Efficacy in Heavier and Lighter Weight Patients With Moderate-to-Severe Psoriasis

Lebwohl, Mark; Yeilding, Newman; Wang, Yuhua; Papp, Kim

Journal of the Dermatology Nurses' Association: March-April 2010 - Volume 2 - Issue 2 - p 85-86
doi: 10.1097/01.JDN.0000350436.76981.05
DEPARTMENTS:Meeting Abstract: Poster Abstracts From the Dermatology Nurses' Association 28th Annual Meeting, 2010 Meeting Abstracts

(Affiliation superscripts pending author clarification) 1 Mount Sinai School of Medicine, New York, NY 2 Centocor Research and Development, Inc. 3 Probity Medical Research, Waterloo, Ontario, Canada

© 2010 Lippincott Williams & Wilkins, Inc.